London South East Investor Webinar - with presentations & Q&A from Power, Cora, Zephyr and VRE Watch Now

Less Ads, More Data, More Tools Register for FREE
London South East Investor Webinar - with presentations & Q&A from Power, Cora, Zephyr and VRE
London South East Investor Webinar - with presentations & Q&A from Power, Cora, Zephyr and VREView Video
Goldplat refocuses on gold recovery operations and returns to profitability in 2020 #GDP
Goldplat refocuses on gold recovery operations and returns to profitability in 2020 #GDPView Video

Pin to quick picksRedx Pharma Regulatory News (REDX)

Share Price Information for Redx Pharma (REDX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 60.00
Bid: 55.00
Ask: 65.00
Change: 2.50 (4.35%)
Spread: 10.00 (18.18%)
Open: 60.00
High: 60.00
Low: 60.00
Yest. Close: 57.50
REDX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
Date   Source Headline
12th Feb 20197:00 amRNSNew in vivo data on ROCK2
6th Feb 201911:25 amRNSReceipt of Outstanding Loan
31st Jan 20197:00 amRNSDeinove return rights to Redx Programme
23rd Jan 201911:25 amRNSResults of Annual General Meeting
21st Jan 20197:00 amRNSRXC004 Trial Approval
10th Jan 20192:05 pmRNSSecond Price Monitoring Extn
10th Jan 20192:00 pmRNSPrice Monitoring Extension
3rd Jan 20197:00 amRNSRedx to present at 2019 Biotech Showcase event
28th Dec 201811:47 amRNSPublication of Annual Report and Accounts
30th Nov 20188:45 amEQSHardman & Co Research: RedX Pharma (REDX): RXC006: First fibrosis development candidate
30th Nov 20187:00 amRNSFirst RXC006 data for treatment of fibrosis
27th Nov 20184:05 pmEQSHardman & Co Research: Redx Pharma (REDX): Streamlined, focused and good value
19th Nov 20187:00 amRNSCFO Announcement
19th Nov 20187:00 amRNSPreliminary Results for year ended 30 Sept 2018
14th Nov 20187:00 amRNSRedx announces new drug development candidate
9th Nov 20189:51 amEQSHardman & Co Research: Redx Pharma (REDX):ROCK2 inhibitors in chronic kidney disease
5th Nov 20187:00 amRNSPreclinical data presented at cancer conference
31st Oct 20187:00 amRNSNotice of Results
29th Oct 20187:00 amRNSRedx notes election of Lisa Anson to UK BIA BOD
26th Oct 20187:00 amRNSDetails from Redx ROCK2 inhibitor poster
22nd Oct 20187:00 amRNSRedx ROCK2 inhibitors poster to be presented
2nd Oct 20181:40 pmEQSHardman & Co Research: Redx Pharma (REX): Strategy launch
6th Sep 20187:15 amEQSHardman & Co Research: Redx Pharma (REDX): Back to the clinic
4th Sep 20187:00 amRNSRedx Pharma Announces Way Forward For RXC004
18th Jun 20187:15 amEQSHardman & Co Research: Redx Pharma (REDX): 'Focus, Realism and Results' - Ian Ross, Chairman
4th Jun 20187:00 amRNSDirectorate Update and Grant of Options
30th May 20187:00 amRNSInterim Results
15th May 201812:00 pmEQSHardman & Co Research: Redx Pharma (REDX): Clinical and corporate update
25th Apr 201810:57 amRNSShare Purchase by Chairman
25th Apr 20189:05 amRNSSecond Price Monitoring Extn
25th Apr 20189:00 amRNSPrice Monitoring Extension
24th Apr 20187:00 amRNSRedx Appoints Senior AstraZeneca Executive as CEO
13th Apr 20188:19 amRNSHolding(s) in Company
12th Apr 201811:28 amRNSHolding(s) in Company
29th Mar 20187:00 amRNSRXC004 Clinical Trial Update
22nd Mar 20187:00 amRNSRedx and Deinove sign option and licence agreement
15th Mar 20187:00 amRNSPoster Presentation at AACR Annual Meeting
6th Mar 20184:33 pmRNSResult of AGM
12th Feb 201810:23 amRNSPosting of Annual Accounts & AGM notice
6th Feb 20187:00 amRNSFirst Patient Dosed in Phase 1/2a Trial of RXC004
22nd Jan 20187:00 amRNSAppointment of Chief Medical Officer
28th Dec 201711:28 amRNSHolding(s) in Company
27th Dec 20175:45 pmRNSShare Purchase by Directors
22nd Dec 20177:00 amRNSGrant of Options
20th Dec 20177:00 amRNSFinal Results for the Year Ended 30 September 2017
14th Dec 20173:56 pmRNSHolding(s) in Company
8th Dec 20175:04 pmRNSHolding(s) in Company
14th Nov 201711:30 amRNSDirector/PDMR Shareholding
13th Nov 20177:15 amRNSHardman Research: Streamlined and clean
6th Nov 201712:00 pmRNSRestoration - Restoration Redx Pharma plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.